Transient vitamin B5 starving improves mammalian cell homeostasis and protein production. by Pourcel, L. et al.
Contents lists available at ScienceDirect
Metabolic Engineering
journal homepage: www.elsevier.com/locate/meteng
Transient vitamin B5 starving improves mammalian cell homeostasis and
protein production
Lucille Pourcela,∗, Flavien Burona, Fanny Garciaa, Margaux-Sarah Delaloixa, Valérie Le Fournb,
Pierre-Alain Girodb, Nicolas Mermoda
a Center for Biotechnology and Department of Fundamental Microbiology, University of Lausanne, UNIL-EPFL, Lausanne, Switzerland
b Selexis SA, 18 Ch. des Aulx, Geneva, Switzerland







A B S T R A C T
Maintaining a metabolic steady state is essential for an organism's fitness and survival when confronted with
environmental stress, and metabolic imbalance can be reversed by exposing the organism to fasting. Here, we
attempted to apply this physiological principle to mammalian cell cultures to improve cellular fitness and
consequently their ability to express recombinant proteins. We showed that transient vitamin B5 deprivation, an
essential cofactor of central cellular metabolism, can quickly and irreversibly affect mammalian cell growth and
division. A selection method was designed that relies on mammalian cell dependence on vitamin B5 for energy
production, using the co-expression of the B5 transporter SLC5A6 and a gene of interest. We demonstrated that
vitamin B5 selection persistently activates peroxisome proliferator-activated receptors (PPAR), a family of
transcription factors involved in energy homeostasis, thereby altering lipid metabolism, improving cell fitness
and therapeutic protein production. Thus, stable PPAR activation may constitute a cellular memory of past
deprivation state, providing increased resistance to further potential fasting events. In other words, our results
imply that cultured cells, once exposed to metabolic starvation, may display an improved metabolic fitness as
compared to non-exposed cells, allowing increased resistance to cellular stress.
1. Introduction
Large amounts of active protein are usually required for functional
and structural analysis, as well as for the production of biological
therapeutics. For most eukaryotic proteins, this also requires homo-
geneous post-translational modifications, as can be achieved by ex-
pression in cultured mammalian cells. Optimization of gene transfer
methods, selection process, protein synthesis and culture conditions are
currently performed to obtain higher yields of recombinant proteins
from stably transfected mammalian cells. Nevertheless, despite sig-
nificant progress, the protein production rate appears to be limited by
intrinsic metabolic bottlenecks in the cells and by the production of
toxic metabolic by-products such as lactate. Changes in the central
metabolism of cultured cells highlighted a regulatory link between
metabolite cellular intake, cell growth and recombinant protein pro-
duction (Dean and Reddy, 2013). Moreover, the maintenance of an
organism's metabolic steady state, also termed energy homeostasis, is
essential for its fitness and survival when confronted with environ-
mental stresses such as starvation, infections or injuries (Kotas and
Medzhitov, 2015). A metabolic unbalance can occur after changes in
nutrient diet, which may activate alternative metabolic pathways in
order to return to a balanced energy state. For instance, the liver
maintains energy homeostasis during fasting by activation of ketogen-
esis, to provide enough energy-yielding nutrients for critical organs
such as brain and muscles (van den Berghe, 1991). In such conditions,
the hepatic acetyl-CoA, a key molecule in central metabolism, will be
converted into ketones instead of entering the TCA cycle (Pietrocola
et al., 2015). These ketones will then enter blood circulation to be taken
up into extra-hepatic cells, reconverted into acetyl-CoA and metabo-
lized by the TCA cycle for ATP production (Puchalska and Crawford,
2017).
The peroxisome proliferator-activated receptors (PPARs) are ligand-
activated transcription factors that belong to the superfamily of nuclear
hormone receptors and play an essential role in energy homeostasis,
cell proliferation and differentiation (Kersten et al., 2000). Three dif-
ferent PPAR subtypes have been identified, termed PPARα, PPARβ/δ
and PPARγ. Fatty acids and derivatives produced in hepatic cells during
starvation activate PPARα, which will in turn induce the transcription
of target genes involved in ketogenesis, lipid metabolism and anti-in-
flammatory response (Kersten et al., 2000; Rakhshandehroo et al.,
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2010). Recent studies have demonstrated that activating the PPAR
signalling pathway in mammals, either by caloric restriction or by in-
creasing the proportion of fatty acid-derived products such as ketones
in the diet, leads to the reduction in oxidative damage and to the in-
duction of autophagy to modulate nutrient recycling. These fasting-
induced mechanisms were shown to improve mammalian lifespan and
general fitness (Lee et al., 2014; Newman et al., 2017; Redman et al.,
2018). Although the beneficial impacts of activating the PPAR pathway
are well described in organisms, the possible occurrence of such fasting-
induced long-term effects have not been studied at the cell culture level.
Moreover, attempts to characterize key components of energy meta-
bolism regulation in cultured cells, a necessary step to engineering their
central metabolism to possibly improve recombinant protein produc-
tion, have not been reported.
Here, we hypothesized that cultured mammalian cells subjected to
nutrient depletion, therefore mimicking a state of fasting, might display
the beneficial properties of improved fitness observed in animals. We
assessed whether stressed-cells could develop a selective advantage due
to the activation of alternative metabolic pathways, leading to im-
proved energy homeostasis. To do so, we designed a metabolic selection
approach based on vitamin B5 deficiency, given the central role of vi-
tamins in cell metabolism and the severe metabolic stress and diseases
elicited by their deprivation (Kobayashi et al., 2011). We showed that
overexpression of SLC5A6, a transporter mediating the uptake of vi-
tamin B5 and biotin (Ghosal et al., 2013; Uchida et al., 2015), can be
used to increase cell growth and viability in conditions of limiting B5
availability. A selection procedure based on SLC5A6 co-expression was
established, yielding populations of CHO cells producing recombinant
proteins at very high and homogeneous levels. Given the central role of
vitamin B5 as an essential cofactor for acetyl-CoA biosynthesis, we
deciphered the genetic and metabolic changes occurring in cells during
B5 selection, to identify a set of PPARα-induced target genes. We show
that transient B5-starvation leads to persistent PPARα activation in
cultured cell populations, improving cell viability in a nutrient-limiting
environment. PPARα activation was found to improve lipid home-
ostasis and to decrease the synthesis of toxic by-products such as lac-
tate, improving the cell metabolic fitness, which was accompanied by
increased production of proteins of interest. We conclude that B5 de-
privation of CHO cell cultures leads to the establishment of a fasting
state, which may overcome the metabolic bottlenecks limiting the ex-
pression of recombinant proteins by cultured cells.
2. Materials and methods
2.1. Vitamin gene sequences and DNA vector constructs
Genomic and cDNA sequences were determined after alignment of
the homologous genes in mice using NCBI BLAST software. Chinese
hamster ovary cells (CHO–K1) cDNAs were produced by reverse tran-
scription from 1 μg of total RNA isolated from 106 cells (NucleoSpin™
RNA kit; Macherey-Nagel) using the GoScript Reverse transcription
System (Promega).
Vectors were constructed as follow: The SLC5A6 coding sequence
was amplified from CHO cell cDNA library by PCR (PHUSION High-
Fidelity DNA Polymerase; Thermo Fisher Scientific) using primers
carrying restriction sites. The amplicon was cloned into the pGAPDH-
MAR 1-68-GFP vector (Selexis Inc.), by cutting out the green fluorescent
protein (GFP) sequence and replacing it with that of SLC5A6. The GFP
protein was expressed using a eukaryotic expression cassette composed
of a human cytomegalovirus (CMV) enhancer and human glycer-
aldehydes 3-phosphate dehydrogenase (GAPDH) promoter upstream of
the GFP coding sequence followed by a simian virus 40 (SV40) poly-
adenylation signal, the human gastrin terminator and a SV40 enhancer
(Le Fourn et al., 2014). The pSV-PURO vector contains the puromycin
resistance gene under the control of the SV40 promoter originating
from the pRc/RSVplasmid (Invitrogen). The blasticidin vector contains
the blasticidin resistance gene under the control of the CMV promoter
originating from the pCMV/Bsd plasmid (Invitrogen). The im-
munoglobulin expression vectors pGAPDH-MAR1-68-IgG-Lc and
pGAPDH-MAR1-68-IgG-Hc expressing the trastuzumab monoclonal im-
munoglobulin (IgG) light chain (Lc) and heavy chain (Hc) were as
previously described (Le Fourn et al., 2014). The TNFR-Fc and In-
fliximab expression vectors were cloned in the same mammalian ex-
pression vectors carrying the puromycin resistance gene.
2.2. Cell culture and stable transfections
CHO cells were maintained in suspension culture in SFM4CHO-M
Hyclone serum-free medium (SFM, Thermo Fisher Scientific) supple-
mented with L-glutamine (PAA) and HT supplement (Gibco) at 37 °C,
5% CO2 in humidified air. Other cell media used for these experiments
are the BalanCD CHO-M Growth A (B-CDfull; Irvine Scientific), and the
Deficient BalanCD CHO-M Growth A (B-CDmin; Irvine Scientific),
supplemented with vitamin B1 (thiamine Hydrochloride; Sigma-
Aldrich), vitamin B5 (Calcium DL-Pantothenate; TC) and vitamin H
(Biotin, Sigma-Aldrich). The BSO3 trastuzumab-expressing cell clone
was generated as as the highest producing clone after several limiting
dilution steps among 192 positive clones, as previously described (Le
Fourn et al., 2014). Transfections were performed as follows: CHO cells
were transformed with PvuI-digested expression vectors by electro-
poration according to the manufacturer's recommendations (Neonde-
vices, Invitrogen). Production of stable cell lines was achieved using
SFM4CHO complete media complemented with 7.5 μg/ml of blasticidin
for 3 weeks for blasticidin selection, 10 mg/ml of puromycin for 9 days
for puromycin selection, or with the B5 deficient media for B5 selection.
B5 selection was performed as follows: One day before transfection,
cells were grown at 300′000 cells/ml in B5 selective media which
consisted in B-CDmin media supplemented with 7.5 μM B1 (1X), 2.5 nM
B5 (10−3X) and 50 pM H (10−4X). After transfection, cells were in-
cubated with B5 selective media for 9–14 days, and then transferred
into SFM non-selective medium. For Puro/B5 double selection, poly-
clonal stable cell lines were first selected with alternance of 10 mg/ml
of puromycin and B5 selective media (10−3X B5/10−4X H) for the
indicated days, then transferred into SFM non-selective media. Stable
clones were isolated by limited dilution or using Clonepix device.
2.3. Analyses of stable polyclonal and monoclonal lines
Fed-Batch Performance Evaluation: Growth and IgG secretion per-
formances in fed-batch culture were performed according to Le Fourn
et al. (Le Fourn et al., 2014), with the following changes: high IgG
producing clones were seeded at 300′000 cells/ml in 5mL culture
medium in falcon of 50 mL. Viable cell density and IgG titers, expressed
as g/L of IgG in the cell culture supernatant, were evaluated after 3, 6, 8
10 and 13 days. TNFR-Fc expressing pools were sub-cultivated in
125 ml shake flasks in 20 ml of culture medium every 3–4 days. IgG
titer in cell culture supernatants was measured by sandwich ELISA. IgG
cell surface staining: Detection of cell surface IgG (i.e. surface staining)
was based on protocol from Brezinsky et al., (Brezinsky et al., 2003), as
described in Harraghy et al., (Harraghy et al., 2012), and modified as
follows: labelling was performed in a 2mL Eppendorf tube, using an
APC-conjugated antibody (Allophycocyanin (APC)-conjugated Affini-
Pure Goat Anti-human IgG (Jackson ImmunoResearch). Moreover, cells
were not fixed. Surface IgG display was assessed by FACS analysis using
a flow cytometry (Beckman Coulter). Single-cell cloning with ClonePix FL
device: Cell pools expressing recombinant IgG protein were subcloned
using ClonePix™ FL Imager from Molecular Devices. Briefly a semi-solid
media was prepared by mixing equal parts of liquid concentrate (2×)
SFM4CHO medium containing L-glutamine and CloneMatrix™ (Mole-
cular Devices). This mix was supplemented with the CloneDetect™ FITC
reagent consisting anti-human IgG antibody conjugated to FITC. Cells
were inoculated in this medium at 200 cells/ml in 6-well plates. Plates
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were then incubated 10 days at 37 °C, 5% CO2, in a humidified in-
cubator. Growing and secreting colonies were detected by Clonepix FL
Imaging software. Highly-secreting colonies were picked and trans-
ferred to 96-well plates containing culture medium. The intensity of the
secretion halo measured by Clonepix FL Imaging software was used to
rank clones and illustrated producers distribution of tested and control
pools. Cell Secretion Assay: The stable IgG expression of transfected CHO
cell lines was analysed with Cell Secretion Assay and Celigo Cell Cyt-
ometer imaging (Celigo S Application, Nexcelom). Briefly, cells were
incubated at 37 °C overnight, with a green-fluorescent cell detection
reagent (CellTracker™ Green CMFDA Dye) and with an anti-human IgG
PE-conjugated antibody. After overnight incubation, culture plates
were imaged using CSA application of Celigo Cell Cytometer. The anti-
human IgG PE-conjugated antibody interacts with the secreted re-
combinant protein by forming fluorescent detectable secretion network
closer to the single cell – the halo of secretion. The % of secreting clones
in polyclonal populations was used to assess the homogeneity of pools.
The analysis of the intensity of the secretion halo was used to estimate
the production level of the total population as well as to determine the
distribution of high (HP), medium (MP) and low-producers sub-
populations (LP). GFP fluorescence: The percentage of fluorescent cells
and the fluorescence intensity of GFP positive cells were determined by
FACS analysis using a CyAn ADP flow cytometer (Beckman Coulte).
2.4. Transient transfection assays of PPAR transcription factors activity
Transient transfection assays were performed as follows: CHO cells
were transfected with PPRE-TK-DsRed (provided by Prof. Michalik,
University of Lausanne), consisting of multiple copies of the PPAR re-
sponse element (PPRE) fused to a minimal thymidine kinase (TK)
promoter located upstream of the dsRed coding sequence, or with TK-
DsRed devoid of the PPRE sequence, with or without the pSG5_PPARα
expression vector (Issemann and Green, 1990). pE-BFP2-Nuc (2xNLS),
used as internal transfection control, contains the eBFP2 (enhanced
blue fluorescent protein 2) coding sequence and a nuclear localization
sequence under the control of minimal CMV promoter (Addgene). Cell
were observed 48 h after transfection by flow cytometry using a Gallios
Flow Cytometer (Beckman Coulte) and the fluorescence was analysed
by Kaluza Acquisition software. The DsRed fluorescence (638 nm) was
standardized relative to that of the BFP2 marker (488 nm).
2.5. RNA PCR and sequencing analysis
For sequencing analysis, cells were grown for 4 days in spin-tubes
without antibiotic selection. Total RNA was isolated from cells using the
NucleoSpin RNA kit (Macherey-Nagel). RNA quality was evaluated
using the Fragment Analyzer (Advanced Analytical). RNA-seq library
preparation was performed using 0.5 μg–1 μg of total RNA converted to
cDNA using the Illumina TruSeq stranded mRNA-seq reagents
(Illumina). The RNA-seq library 100nt paired end was sequenced on the
Illumina HiSeq 2500. Reads were mapped to the CHO–K1 transcriptome
(Pruitt, 2014). Cells used for the RNASeq analysis were the following:
1) CHO cells; 2) Clones expressing the interferon beta and SLC5A6;
selected with puromycin/B5, or with puromycin only 3) Polyclonal cell
population expressing the trastuzumab and SLC5A6 selected with pur-
omycin/B5, or with puromycin only. For real time quantitative PCR
(RT-qPCR) analysis, total RNA was extracted from 106 cells and reverse
transcribed into cDNA. Transcripts accumulation was quantified by RT-
qPCR using the SYBR Green-Taq polymerase kit from Eurogentec Inc.
and ABI Prism 7700 PCR machine (Applied Biosystems). Transcript
levels were normalized to that of GAPDH housekeeping gene.
2.6. Metabolite analyses (metabolite extraction, sample amount
normalization)
Metabolite extraction: For metabolite quantification, cell pellets were
extracted with 1 mL of cold MeOH:H2O (4:1, v/v) solvent mixture as a
best compromise to efficiently precipitate proteins, quench the meta-
bolism and extract a broad range of polar metabolites. The samples
were then probe-sonicated (4 pulses x 5 s) to lyse the cells completely
and improve the metabolite extraction. To promote protein precipita-
tion, the samples were incubated for 1 h at −20 °C, followed by 15 min
centrifugation at 13,000 rpm at 4 °C. The resulting supernatants were
collected and evaporated to dryness in a vacuum concentrator
(LabConco). Then, the sample extracts were reconstituted in 100 μL
MeOH:Water (4:1) and injected into the LC-MS system. Protein quanti-
fication: The protein pellets were evaporated and lysed in 20 mM Tris-
HCl (pH 7.5), 4 M guanidine hydrochloride, 150 mM NaCl, 1 mM
Na2EDTA, 1 mM EGTA, 1% Triton, 2.5 mM sodium pyrophosphate,
1 mM beta-glycerophosphate, 1 mM Na3VO4, 1 μg/ml leupeptin using
brief probe-sonication (5 pulses x 5 s). The BCA Protein Assay Kit
(Thermo Fisher Scientific) was used to measure total protein con-
centrations (Hidex). Data acquisition – LC-HRMS: Extracted samples
were analysed by Hydrophilic Interaction Liquid Chromatography
coupled to high resolution mass spectrometry (HILIC - HRMS) in ne-
gative ionization modes using a Q-Exactive instrument (Quadrupole
Orbitrap mass spectrometer) (Thermo Fisher Scientific) operating at
mass resolving power of 70,000 full width half maximum (FWHM).
Metabolites were separated by chromatography using a ZIC pHILIC
(100 mm, 2.1 mm I.D. and 5 μm particle size) column. The mobile
phase was composed of A = 20 mM ammonium Acetate and 20 mM
NH4OH in water at pH 9.3 and B = 100% ACN. The linear gradient
elution from 90% B (0–1.5 min) down to 50% B was applied
(1.5 min–8 min), followed by an isocratic step (8 min–11 min) and
linear gradient down to 45% B (11 min–12 min). These conditions were
held 3 min. Finally, the initial chromatographic conditions were es-
tablished as a post-run during 9 min for column re-equilibration. The
flow rate was 300 μL/min, column temperature 30 °C and sample in-
jection volume 2.5 μl. ESI source conditions were set as follows: probe
heater temperature 200 °C, sheath gas 60 a.u., auxiliary gas 15 a.u.,
capillary temperature 280 °C and ESI spray voltage −3600 V. Full scan
mode was used as acquisition mode to quantify lactate, pyruvate, 3-
hydroxybutyrate and pantothenic acid, while acetyl-CoA was quantified
using parallel reaction monitoring (PRM) acquisition mode using 30 eV
as collision energy. Data processing: Raw LC-HRMS data was processed
using the Thermo Fisher Scientific software (Xcalibur 4.0 QuanBrowser,
Thermo Fisher Scientific). Metabolite quantification was performed
using external calibration curves.
2.7. Statistical analysis
The results are expressed as means ± standard error of the mean
(SEM). Statistical analyses were performed using the Student's t-test,
with variance equality depending on sample variance F-test. Asterisks
in the figure panels refer to statistical probabilities p values of less than
or equal to 0.05, which were considered as statistically significant.
3. Results and discussion
3.1. Determination of vitamin-limiting cell growth conditions
We chose to specifically focus on vitamins B5, H and B1, as they are
involved in key mitochondrial functions for energy production (Ghosal
et al., 2013; Lindhurst et al., 2006; Subramanian et al., 2012). To assess
the effect of limiting the concentration of the vitamins on cell growth,
we designed a cell culture medium specifically depleted of vitamins B5,
H and B1, termed B-CDmin. CHO cells seeded in the B-CDmin medium
were unable to maintain cell divisions, as expected (Fig. 1A). Over time,
cell size was reduced, and cells started to lose viability after 6 days of
incubation in the vitamin-lacking medium (Figs. S1A and S1B). The B-
CDmin medium was next complemented with known amounts of the
vitamins, setting standard B5, H and B1 concentrations (1X) at 2.5μM,
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Fig. 1. CHO cells growth in vitamin-deficient media. (A) Cells were seeded in a B-CDmin medium supplemented or not with vitamin B1, B5 or H. Viable cell
density was measured after at 3, 6 and 10 days of culture. (B) CHO cell were co-transfected with the SLC5A6 expression vector, or an empty vector control devoid of
the SLC5A6 coding sequence, together with a puromycin resistance vectors, and polyclonal populations were selected for puromycin resistance. Cells were seeded in
B-CDmin medium supplemented with the indicated amounts of vitamin B5 and H, and with B1 (1X). Viable cell density was measured after 6 days of culture. Non
transfected cells and transfected cells without SLC5A6 vector (Empty) were used as controls. **P≤ 0.02 (t-test; 2 tails) with respect to non-transfected cells within
the same condition of growth and culture medium. Detailed control parameters for cultivations are given in Methods. (C) Experimental cell selection workflow. CHO
cells were co-transfected without or with the SLC5A6 expression vector, together with the ETE trastuzumab and the puromycin resistance vectors, after which cells
were selected either in presence of puromycin (conditions A and B) or in the B5-deficient culture medium (condition C and B). After selection, cells were transferred
to a non-selective culture medium. The crossed circle indicates that cells did not survive selection. (D) SCL5A6 and IgG chains mRNA levels of cell pools A, B and C.
Relative mRNA level was determined by RT-qPCR. **P ≤ 0.02 with respect to condition A (t-test; 2 tails). (E) IgG secretion assays of cell pools A, B and C, as
represented by the specific productivity assayed by double sandwich ELISA. *P≤ 0.05 with respect to condition A (t-test; 1 tail). (F) IgG titers from cell pools A, B
and C, measured after 3 days-batch culture in non-selective medium. *P≤ 0.05 with respect to condition A (t-test; 1 tail). (G) Lactate content in cell pools from A and
C, after 6 days of a fed-batch culture, measured by LC-MS. **P ≤ 0.02 with respect to condition A (t-test; 2 tails). Data are mean values ± SEM from 3 replicates.
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0.5μM and 7.5μM, respectively, as found in commonly used complete
media. In the culture medium deprived solely of B5, cells did not divide,
and viability decreased after 6 days, as in the B-CDmin medium. When
either B1 or H was depleted, cells were able to divide for 3–6 days
respectively, and growth was reduced overall as compared to the full
media. Therefore, we concluded that B5 was most limiting for cell
growth in the short term, as it must be present continuously in the
culture medium to allow cell division.
Vitamin B5 shares a common single cytoplasmic transporter with
vitamin H termed SLC5A6 (Fig. S1C). As competition of B5 and H
transport may occur during vitamin uptake into the cell, we assessed
cell division in culture media containing various concentrations of both
vitamins. The B-CDmin medium was complemented with lower con-
centrations of each vitamin separately, to determine the concentration
range limiting cell growth after 6 days of culture. Because B5 is most
limiting for cell growth, we decreased H concentration by four orders of
magnitude (10−4X) to 50 pM, in order to increase the transporter
availability for B5. In these conditions, B5 was essential for CHO cell
growth, with a growth-limiting concentration range of B5 around
10−3X (2.5 nM) and near-maximal growth at 1X (Figs. S1D and S1E).
However, further addition of B5 up to a 10-fold excess inhibited cell
growth, as expected from a competition between B5 and H for uptake
by the SLC5A6 transporter. These findings implied that overexpression
of the SLC5A6 transporter might provide an advantage to cells grown in
a B5-limiting medium. This was assessed by generating polyclonal po-
pulations stably overexpressing SLC5A6, which were then grown in the
B-CDmin medium supplemented with various concentrations of B5 and
H (Fig. 1B). No significant growth difference was observed when
comparing polyclonal cell lines cultured with 1X B5 and 10−4X H upon
overexpression of SLC5A6. As previously observed, cell division nearly
stopped in the complete absence of B5 after 6 days of culture, irre-
spective of the overexpression of the transporter or in the presence of
vitamin H. Interestingly, when excess B5 was added in the presence of
the low H amount (10X B5/10−4X H), cells overexpressing SLC5A6
divided significantly more than control cells. This further indicated the
occurrence of a competition of the two vitamins for their common
transporter, where saturating concentrations of B5 may limit growth by
inhibiting the uptake of low amounts of H in the culture medium, unless
the transporter is overexpressed. More strikingly, cells transfected with
the SLC5A6 expression vector reached significantly higher cell densities
in B5 limiting condition (10−3X B5/10−4X H). Moreover, while cells
without exogenous transporter overexpression did not survive culture
in the B5-limiting medium, cells overexpressing SLC5A6 survived B5
deprivation, and they recovered a normal growth when further trans-
ferred into complete media (1X B5/1X H, data not showed). Overall, we
concluded that overexpression of the SLC5A6 transporter can confer a
growth advantage that is most significant in presence of either satur-
ating concentrations of B5 (10X) and limiting amounts of H (10−4X), or
conversely in the presence of limiting concentrations of B5 (10−3X). We
next attempted to use this approach to establish a selection strategy for
cells that express elevated amounts of SLC5A6 from those that express it
at lower levels.
3.2. SLC5A6 expression and B5 deprivation as a metabolic selection for
transfected cell lines
We designed a B5-selection approach to select recombinant cells
expressing the trastuzumab therapeutic immunoglobulin (IgG) or the
green fluorescent protein (GFP) marker (Fig. 1C, Fig. S2A). CHO cells
were co-transfected without (condition A) or with (conditions B and C)
the SLC5A6 expression vector, together with the IgG or the GFP ex-
pression vectors along with a puromycin resistance marker. Subse-
quently, the culture was selected either in presence of puromycin
(conditions A and B) or in the vitamin B5-deprived culture medium
(10−3X B5/10−4X H, condition C). Control cells that had not been
transfected with the SLC5A6 expression vector did not survive selection
in the vitamin-deprived culture medium. After selection, cells were
transferred into a non-selective medium until the analysis of the re-
sulting polyclonal cell pools. Higher levels of IgG and GFP mRNAs and
proteins were obtained from cells transfected with the SLC5A6 ex-
pression vector and selected using B5 deprivation, when compared to
cells selected for puromycin resistance (Fig. 1D–F, Figs. S2B–E). Inter-
estingly, single cell assays of GFP fluorescence indicated that condition
C was capable of selecting cell populations displaying very high and
homogeneous levels of transgene expression. Liquid-chromatography-
mass spectrometry (LC-MS) metabolic analyses showed a decrease of
lactate by-product after SLC5A6 overexpression and B5 deprivation
(Fig. 1G). Ten IgG clones were randomly isolated by limiting dilutions
of the polyclonal cell populations obtained from selection conditions B
and C. The IgG secretion levels of clones obtained from cells selected
using condition C were consistently higher than those of condition B
(Figs. S3A and S3B). Two randomly-selected clones isolated from se-
lection condition C displayed stable IgG secretion levels when main-
tained in complete non-selective medium for over two months of cul-
ture, indicating that a continuous selection for SLC5A6 expression is not
required (Fig. S3C). Both clones showed comparable performance re-
lative to a high-IgG expressor reference clone selected as the best
among 192 clones, in terms of cell growth, viability and IgG secretion
(Figs. S3D–F) illustrating the effectiveness of the novel selection process
reported in this study. Overall, these data indicate that the cell selection
process relying on SLC5A6 transporter expression and B5 selective
medium provides consistent and homogeneous polyclonal populations,
from which highly-expressing clones can be isolated at a high fre-
quency.
The trastuzumab IgG is considered to be an “easy-to-express” (ETE)
recombinant protein, as no major cellular bottleneck affects its pro-
duction, with final yields in a bioreactor surpassing 1g/L. However,
cells may struggle to produce high levels of recombinant IgG-fusion or
chimeric proteins termed “difficult-to-express” (DTE), because of poorly
understood metabolic limitations (Le Fourn et al., 2014). As the B5
selection process may be too stringent for cells struggling to express a
DTE protein (termed hereafter DTE cells), we set up a milder B5-se-
lection process by combining antibiotic and short (5 days) B5-depri-
vation selection of cells transfected with both antibiotic resistance and
SLC5A6 selection vectors. This method was first assessed with ETE cells
expressing the trastuzumab IgG (Fig. S4A). Cells subjected to the double
antibiotic/B5 selection yielded more than 2-fold higher IgG production
levels when compared to the single antibiotic selection (Fig. 2A; Fig.
S4C), as mediated by the selective enrichment of a minor subpopulation
of cells displaying very high IgG secretion levels (Fig. 2B). This effect
required SLC5A6 overexpression, as expected (Figs. S4B and S4D). A
similar enrichment of a minor subpopulation of cells expressing the
transgene at highly elevated levels was also observed with GPF upon
the double antibiotic/B5 selection of SLC5A6 overexpressing cells (Figs.
S5 and S6). We next assessed whether this approach may be used to
express the DTE TNFR-Fc fusion proteins, which consists of a chimeric
protein comprising the receptor of the Tumor Necrosis Factor (TNFα)
fused to the IgG constant chain (Fc). TNFR:Fc acts as a potent regulator
of the inflammatory response resulting from autoimmune diseases, for
which utilization as therapeutics is limited by very low levels of se-
cretion, recovery and purification (Pybus et al., 2014). Cells were co-
transfected with the puromycin and TNFR:Fc expression vectors or with
these vectors plus SLC5A6, and were alternatively selected with pur-
omycin and vitamin B5 limitation for 19 days (Fig. S7A). Recombinant
cells subjected to the double antibiotic/B5 selection displayed much
higher IgG secretion levels when compared to the cells subjected to
antibiotic selection only (Fig. 2C–E; Figs. S7B and S7C). When the ex-
pression of the fusion protein was assessed in fed-batch cultures, the
doubly selected cells displayed higher overall protein levels, despite
lower cell numbers at the end of the culture time (Fig. 2F). Overall,
these data indicated that SLC5A6 and vitamin B5-mediated selection
can also be used in conjunction with antibiotic selection to
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preferentially select the cells that mediate the highest transgene ex-
pression levels, even when expressing DTE proteins that cannot be
obtained at high levels using conventional selection methods.
3.3. B5 deprivation alters expression of PPAR-regulated lipid metabolism
genes
The ability to express DTE proteins at high levels when using the
vitamin B5 deprivation approach, and thus to bypass potential meta-
bolic bottlenecks, suggested that this selection strategy may allow for
the isolation of a minor fraction of variant cells bearing favourable
genetic and/or epigenetic alterations. This was assessed using a RNA-
seq transcriptomic analysis of cells producing the trastuzumab ETE or
the beta-interferon DTE protein whose production is severely limited by
protein aggregation (Han et al., 2009), comparing antibiotic/B5-, an-
tibiotic- and non-selected cell populations (Fig. S8A). Genes whose
expression was significantly upregulated in antibiotic/B5 vs. antibiotic
selection in cells expressing either ETE and DTE proteins were selected
for further analysis. Most selected genes displayed decreased expression
after antibiotic-selection of recombinant protein-expressing cells, when
compared to non-transfected cells (Figs. S8B and S8C). This effect was
reversed or even overcompensated in antibiotic/B5-selected cells, along
with the observed increase in recombinant protein expression. This
suggested the possible occurrence of a cellular response caused by the
recombinant protein itself or by the competition of its expression for
limiting metabolic cellular functions after antibiotic selection. How-
ever, this effect would be suppressed upon B5 selection, if B5 depri-
vation may select cells having a persistently improved fitness and me-
tabolism, and a correspondingly increased capacity for high level
recombinant protein expression.
Among the 31 candidate genes selected as B5-selection targets, 14
were attributed to the biological activity or expression of the re-
combinant protein themselves, being categorized as immune response-
associated (Fig. 3A; Table S1). Eleven were metabolic genes encoding
enzymes and transporters, as might be expected from adaptive changes
to their primary metabolism. Interestingly, five of these genes were
involved in lipid metabolism, among which three, HMGCS2, ACOT1
and CYP4A14, are known targets of PPARα (Rakhshandehroo et al.,
2010). Hydroxymethylglutaryl CoA synthase 2 (HMGCS2) encodes a mi-
tochondrial protein that catalyses the first reaction of ketogenesis and
controls the metabolic fate of fatty acids in the liver of starved animals
(Vila-Brau et al., 2011). ACOT1 encodes an acyl-CoA thioesterase
Fig. 2. Enrichment of ETE and DTE protein
expressing cells by antibiotic and B5 double
selection. (A–B) Cells were co-transfected
with the ETE trastuzumab, SLC5A6, and pur-
omycin resistance vectors, after which the
culture was selected either in presence of
puromycin, or by puromycin selection fol-
lowed by 5 days of culture in B5-deficient
medium. Selected cells were transferred to a
non-selective culture medium followed by IgG
secretion assays (A) and the analysis by cyto-
fluorometry of IgG cell surface display as-
sessed by immunofluorescence staining (B).
Data are mean values ± SEM from 3 in-
dependent pools. **P ≤ 0.02 (t-test; 2 tails)
vs. antibiotic selection. (C–F) Cells were co-
transfected with or without the SLC5A6
vector, and the DTE TNFR:Fc fusion and pur-
omycin resistance vectors, after which the
cultures were selected using puromycin only,
or by consecutive selection steps performed
using the B5-deficient medium and puromycin
selection. Selected cells were transferred to a
non-selective culture medium prior to ana-
lysis. (C–D) Cell secretion assay was used to
assess the homogeneity and estimate the level
of producing cells for puromycin- and pur-
omycin/B5-selected pools. ClonePix FL
Imager was used to rank and isolate cells ac-
cording to their secretion halo intensity (E)
and TNFR:Fc production assays were per-
formed using fed-batch cultures of the clone
with the highest secretion halo intensity ob-
tained from puromycin- or puromycin/B5-se-
lection (F).
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(CoASH) involved in long chain fatty-acid metabolism which catalyses
the hydrolysis of acyl-CoAs to release free fatty acid and coenzyme A.
CYP4A14 is a cytochrome P450 implicated in liver damage, in-
flammation, and fibrosis in mice (Zhang et al., 2007).
As PPARα mRNA levels were not persistently increased following
antibiotic/B5 double selection, we next assessed whether the increase
of PPARα target genes expression could result from the activation of
this transcription factor by endogenous ligands that may be synthesized
by B5-selected cells. B5-selected and antibiotic-selected cells were
transfected with the PPRE-DsRed reporter of PPAR transcriptional ac-
tivity with or without a PPARα expression vector, and DsRed fluores-
cence was assessed. Interestingly, exogenous expression of PPARα ac-
tivated the PPAR responsive promoter to higher levels in B5- vs.
antibiotic-selected cells (Fig. 3B; Fig. S9). Therefore, we hypothesized
that B5 deprivation and the resulting starving stress may have yielded
cells that persistently produce a PPARα agonist, and thus, that would
express PPARα target genes at higher levels (Fig. S10).
3.4. PPAR activation improves cell resistance to stress
We next aimed to assess whether the gene expression changes in-
duced by B5 starving and/or PPAR activation may result in reduced
unhealthy by-products and/or improved cell metabolic fitness, thereby
providing an explanation for their ability to efficiently express complex
recombinant proteins. Bezafibrate (2-[4-[2-(4-chlorobenzamido)ethyl]
phenoxy]-2-methylpropanoic acid) is a general PPAR pan-agonist used
clinically as an anti-hyperlipidaemia drug (Inoue et al., 2002). Addition
of bezafibrate to a fed batch culture of ETE protein-expressing cells
induced the HMGCS2 and ACOT1 PPARα target genes, as well as sev-
eral other known PPAR targets such as DBI1, ASCL1 and the RXR nu-
clear receptor (Rakhshandehroo et al., 2010) (Fig. 4A). Interestingly,
another B5-selection induced gene, SLC22A14, was also activated in
response to bezafibrate. While the SLC22A14 transporter has been
linked to sperm mobility and fertility in mice (Maruyama et al., 2016),
a potential PPAR-associated function has not been described as yet,
although a PPRE regulatory sequence was identified upstream of its
gene (Tzeng et al., 2015). Bezafibrate was added to the cells at day 3,
during the culture exponential phase, and its effect on cell growth and
IgG secretion was observed up to 10 days of fed or non-fed cultures.
When the cells were subjected to a feeding stress, by omitting the ad-
dition of feed supplements to the cell culture, bezafibrate-treated cells
survived and kept secreting the IgG, whereas non-treated cells rapidly
died (Fig. 4B). In contrast, upon feeding, cells growth and IgG pro-
duction were rather decreased by bezafibrate addition. Thus, we con-
cluded that the induction of PPAR target genes by bezafibrate was
beneficial in cell stress conditions linked to nutrient deprivation, sup-
porting a role for PPAR in maintaining cell fitness and energy home-
ostasis, and/or in reducing the accumulation of toxic metabolic by-
products such as lactate.
3.5. PPAR activation affects lipid metabolism and improves recombinant
protein secretion
To assess the effect of PPARα on cell metabolism, antibiotic-selected
clones expressing the trastuzumab ETE protein were transfected with a
mouse PPARα cDNA expression vector. Cells stably overexpressing the
transcription factor were selected for resistance to another antibiotic.
The resulting ETE clones overexpressing PPARα displayed elevated
expression of HMGSC2, ACOT1, CYP4A14 and SLC22A14 genes, sug-
gesting that intracellular PPAR agonists were available in the cells to
activate the exogenous PPARα (Fig. S11). Interestingly, the PPARα-
overexpressing clones showed an improved IgG specific production
compared to control clones, yielding a 30% increase of the titers, to
over 2 g/L (Fig. 5A and B). This indicated that activation of PPAR target
genes by either the B5 selection approach or by PPARα overexpression
yielded similar improvements of the cells’ ability to express the re-
combinant protein at high levels.
A DTE cell clone transfected to overexpress PPARα similarly in-
creased recombinant protein productivity, and this increase was further
amplified by a five days B5-deprivation treatment, indicating that the
two approaches may be combined to further boost recombinant protein
production (Fig. 5C; Fig. S12). Metabolite quantification of these
PPARα overexpressing cells indicated decreased intracellular con-
centrations of vitamin B5, lactate and the ketone body 3-HB and an
increase in acetyl-CoA (Fig. 5D–G). Since vitamin B5 is a precursor of
acetyl-CoA, this indicated that PPARα overexpressing cells may have an
accelerated turnover of the vitamin, thus providing more acetyl-CoA, as
required for cellular energy production by the Krebs cycle, as well as for
lipid metabolism (Fig. S13). Thus, we concluded that activation of
PPARs and their target genes by a fasting state induced by vitamin B5
deprivation and/or by PPARα overexpression, may collectively mod-
ulate metabolite balances by decreasing the production of toxic lactate
by-products, as well as by altering lipid metabolism and the synthesis of
derived ketones bodies. This may in turn improve cell fitness, leading to
an increased capacity to produce the recombinant protein of interest.
4. Conclusion
In the present work, we first aimed to capitalize on mammalian cell
dependence on vitamin B5 for central metabolism balance, in order to
select cells with improved fitness and energy homeostasis, as required
to efficiently express complex therapeutic proteins. We established a
selective metabolic procedure based on a SLC5A6 multivitamin trans-
porter and vitamin B5 deprivation, providing a powerful selection for
cells expressing transgenes at high levels, either alone or in combina-
tion with other selection procedures. Unlike other processes based on
the selection of cells with the spontaneous co-amplification of the se-
lection marker and of the transgene of interest, such as in the DHFR
metabolic selection (Cacciatore et al., 2010), use of the SLC5A6-based
Fig. 3. PPARα activation studies in antibiotic- and B5-se-
lected cells producing an ETE protein. (A) Ontological classes
of the identified candidate genes whose expression may be
persistently modified by limiting vitamin B5 selection. (B)
Antibiotic-selected ETE cells and B5-selected ETE (trastu-
zumab) cells were transiently transfected with the PPRE-
DsRed reporter, or cotransfected with the PPRE reporter and
mouse PPARα cDNA. DsRed activity was standardized re-
lative to BFP2 marker. Data represent mean
fluorescence± SEM of corrected DsRed activity from 4 re-
plicates. *P ≤ 0.05 and **P ≤ 0.02 (t-test; 2 tails) with re-
spect to antibiotic-selected cells without exogenous PPARα,
unless otherwise indicated. Negative control of DsRed con-
struct without PPRE is presented in supplemental data (S
Fig. 9).
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selection process does not require lengthy gene amplification steps, and
it yielded stable levels of expression after the removal of the selection
pressure. The B5 selection does not require the cells to acquire a re-
sistance to toxic compounds such as antibiotics, and it has a potential
for use in the field of gene and cell therapy, as it may face fewer ethical
or safety issues than traditional methods.
We showed that B5-deprivation or PPARα overexpression alone
were effective to improve cell recombinant protein production, but that
a combination of the two further enhanced this effect. We provide
evidence that cells transiently deprived of vitamin B5 may have ac-
quired persistent alterations in their lipid metabolism, as mediated by
the activation of PPARα transcription factor. Using the general che-
mical PPAR agonist bezafibrate, we showed that PPAR signalling acti-
vation can protect cells from dying upon a stress caused by feeding
deprivation. Overall, we propose a role for PPARs in the maintenance of
central cellular energy balance, in improved cell fitness and in reduced
synthesis of toxic metabolism by-products. These effects may combine
to allow increased production of recombinant proteins, including dif-
ficult-to-express proteins known to elicit detrimental cellular stress re-
sponses (Fig. S14). Further analysis of the changes in metabolic fluxes
activated by the PPAR and by the fasting process will be required to
decipher the mechanisms behind those metabolic alterations and what
their relative contributions may be to increasing cell fitness (Pourcel
et al., 2020; Berger et al., 2020). So far, the PPAR activation and sig-
nalling pathway has been mainly studied at the whole organism level,
PPAR being expressed and activated in specific tissues (e.g. liver cells
for PPARα) to act distantly, for instance by providing the required
substrate for energy production by muscle fibers. Here, we show that
PPARs may control important functions in other cell types such as
cultured ovary cells, allowing them to maintain a high fitness when
subjected to the metabolic stress conditions of fed batch cultures, when
the cells reach high densities and mediate elevated protein production
levels.
As the PPARs are known to be activated upon food starvation, we
hypothesize that B5 deprivation led to a fasting state of the cells, re-
sulting in the production of one or several as yet unknow PPAR ligands.
The synthesis of such ligand would persist even after B5 deprivation is
terminated and cells are grown in complete medium, thus explaining
the observed persistent activation of PPAR target gene expression. This
event might thus be considered as a cellular memory of the deprivation
state, providing increased resistance to further potential fasting events.
In other words, our results imply that cultured cells, once exposed to
metabolic starvation, may display an improved metabolic fitness as
compared to non-exposed cells, allowing increased resistance to cellular
stresses. However, whether this may stem from e.g. epigenetic changes
specifically elicited by the fasting state, or by the fast selection of a
minority of pre-existing cells having spontaneously increased PPAR
signalling, and thus surviving selection by the starvation stress, remains
to be established.
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